Catalyst Pharmaceuticals (CPRX) Accumulated Depreciation & Amortization (2011 - 2026)
Catalyst Pharmaceuticals posted quarterly Accumulated Depreciation & Amortization of -$3000.0 for Q1 2026, up 98.41% year-on-year from -$1512.0 in Q1 2025, and up 99.5% on a QoQ basis from -$604000.0 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 16 years of Accumulated Depreciation & Amortization data on file, last reported at -$3000.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 98.41% year-over-year to -$3000.0; the trailing twelve-month figure through Mar 2026 stood at -$3000.0 (up 98.41% YoY), and the FY2025 full-year result was -$604000.0, down 98.68% from the prior year.
- Accumulated Depreciation & Amortization for Q1 2026 stood at -$3000.0, up from -$604000.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $98000.0 in Q3 2022 and bottomed at -$1.2 million in Q2 2023.
- The 5-year median for Accumulated Depreciation & Amortization is -$524000.0 (2024), against an average of -$499823.5.
- The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization surged 110.89%; it then slumped 868.37% in 2023.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at -$847000.0 in 2022, then jumped by 75.91% to -$204000.0 in 2023, then sank by 49.02% to -$304000.0 in 2024, then plunged by 98.68% to -$604000.0 in 2025, then soared by 99.5% to -$3000.0 in 2026.
- The last three Accumulated Depreciation & Amortization figures came in at -$3000.0 (Q1 2026), -$604000.0 (Q4 2025), and -$1000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -604,000.00 |
| Dec 31, 2025 | -604,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -716,000.00 |
| Jun 30, 2025 | -716,000.00 |
| Mar 31, 2025 | -189,000.00 |
| Mar 31, 2025 | -189,000.00 |
| Dec 31, 2024 | -304,000.00 |
| Dec 31, 2024 | -304,000.00 |
| Sep 30, 2024 | -389,000.00 |
| Sep 30, 2024 | -389,000.00 |
| Jun 30, 2024 | -524,000.00 |
| Jun 30, 2024 | -524,000.00 |
| Mar 31, 2024 | -317,000.00 |
| Mar 31, 2024 | -317,000.00 |
| Dec 31, 2023 | -204,000.00 |
| Dec 31, 2023 | -204,000.00 |
| Sep 30, 2023 | -753,000.00 |
| Sep 30, 2023 | -753,000.00 |
| Jun 30, 2023 | -1.15 Mn |
| Jun 30, 2023 | -1.15 Mn |
| Mar 31, 2023 | -852,000.00 |
| Mar 31, 2023 | -852,000.00 |
| Dec 31, 2022 | -847,000.00 |
| Dec 31, 2022 | -847,000.00 |
| Sep 30, 2022 | 98,000.00 |
| Sep 30, 2022 | 98,000.00 |
| Jun 30, 2022 | -866,000.00 |
| Jun 30, 2022 | -866,000.00 |
| Mar 31, 2022 | -874,000.00 |
| Mar 31, 2022 | -874,000.00 |
| Dec 31, 2021 | -908,000.00 |
| Dec 31, 2021 | -908,000.00 |
| Sep 30, 2021 | -900,000.00 |
| Sep 30, 2021 | -900,000.00 |
| Jun 30, 2021 | -779,000.00 |
| Jun 30, 2021 | -779,000.00 |
| Mar 31, 2021 | -810,000.00 |
| Mar 31, 2021 | -810,000.00 |
| Dec 31, 2020 | 47,000.00 |
| Dec 31, 2020 | 47,000.00 |
| Sep 30, 2019 | 140,557.00 |
| Sep 30, 2019 | 140,557.00 |
| Jun 30, 2019 | 134,026.00 |
| Jun 30, 2019 | 134,026.00 |
| Mar 31, 2019 | 130,468.00 |
| Mar 31, 2019 | 130,468.00 |
| Dec 31, 2018 | 197,147.00 |
| Dec 31, 2018 | 197,147.00 |
| Sep 30, 2018 | 184,654.00 |
| Sep 30, 2018 | 184,654.00 |
| Jun 30, 2018 | 175,360.00 |
| Jun 30, 2018 | 175,360.00 |
| Mar 31, 2018 | 167,184.00 |
| Mar 31, 2018 | 167,184.00 |
| Dec 31, 2017 | 159,169.00 |
| Dec 31, 2017 | 159,169.00 |
| Sep 30, 2017 | 152,234.00 |
| Sep 30, 2017 | 152,234.00 |
| Jun 30, 2017 | 139,395.00 |
| Jun 30, 2017 | 139,395.00 |
| Mar 31, 2017 | 126,438.00 |
| Mar 31, 2017 | 126,438.00 |
| Dec 31, 2016 | 113,480.00 |
| Dec 31, 2016 | 113,480.00 |
| Sep 30, 2016 | 101,516.00 |
| Sep 30, 2016 | 101,516.00 |
| Jun 30, 2016 | 92,036.00 |
| Jun 30, 2016 | 92,036.00 |
| Mar 31, 2016 | 83,272.00 |
| Mar 31, 2016 | 83,272.00 |
| Dec 31, 2015 | 70,074.00 |
| Dec 31, 2015 | 70,074.00 |
| Sep 30, 2015 | 99,575.00 |
| Sep 30, 2015 | 99,575.00 |
| Jun 30, 2015 | 130,316.00 |
| Jun 30, 2015 | 130,316.00 |
| Mar 31, 2015 | 121,341.00 |
| Mar 31, 2015 | 121,341.00 |
| Dec 31, 2014 | 113,193.00 |
| Dec 31, 2014 | 113,193.00 |
| Sep 30, 2014 | 105,221.00 |
| Sep 30, 2014 | 105,221.00 |
| Jun 30, 2014 | 97,986.00 |
| Jun 30, 2014 | 97,986.00 |
| Mar 31, 2014 | 91,903.00 |
| Mar 31, 2014 | 91,903.00 |
| Dec 31, 2013 | 92,446.00 |
| Dec 31, 2013 | 92,446.00 |
| Sep 30, 2013 | 86,740.00 |
| Sep 30, 2013 | 86,740.00 |
| Jun 30, 2013 | 81,033.00 |
| Jun 30, 2013 | 81,033.00 |
| Mar 31, 2013 | 75,327.00 |
| Mar 31, 2013 | 75,327.00 |
| Dec 31, 2012 | 69,963.00 |
| Dec 31, 2012 | 69,963.00 |
| Sep 30, 2012 | 67,310.00 |
| Sep 30, 2012 | 67,310.00 |
| Jun 30, 2012 | 64,585.00 |
| Jun 30, 2012 | 64,585.00 |
| Dec 31, 2011 | 59,074.00 |
| Dec 31, 2011 | 59,074.00 |